• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 465019 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1417087617 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1417087617 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Arena Pharmaceuticals Crosses Above its 10-day MA (ARNA)

Published on Fri, 03/22/2013 - 11:14
By Peter Chu

Arena Pharmaceuticals (NASDAQ:ARNA) shares have crossed bullishly above their 10-day moving average of $8.07 on a volume of 4.7 million shares. Swing traders may find an opportunity for a long position, as such a crossover often suggests higher prices in the near term.

There is potential upside of 11.4% for shares of Arena Pharmaceuticals based on a current price of $8.26 and an average consensus analyst price target of $9.20. The stock should run into initial resistance at its 50-day moving average (MA) of $8.64 and subsequent resistance at its 200-day MA of $8.81.

Arena Pharmaceuticals, Inc. is a biotechnology company that has developed a receptor-based screening assay using their own CART technology.

Arena Pharmaceuticals share prices have moved between a 52-week high of $13.50 and a 52-week low of $1.77 and are now trading 367% above that low price at $8.26 per share. Over the past week, the 200-day moving average (MA) has gone up 0.3% while the 50-day MA has declined 1.4%.

By Peter Chu
pchu@fnno.com

Latest News from FNNO

Watch for Continued Gains in Shares of V...

Shares of Varian Medical Systems (NYSE:VAR) traded at a new 52-week high today of $89.6 ...

UnitedHealth: The Winning Streak Continu...

Shares of UnitedHealth (NYSE:UNH) traded today at $98.74, breaking its 52-week high. A ...

Texas Instruments: 52-Week High Recently...

Shares of Texas Instruments (NYSE:TXN) traded at a new 52-week high today of $53.74. T ...

Recent 52-Week High Exceeded in Shares o...

Taiwan Semiconductor Manufacturing (NYSE:TSM) traded at a new 52-week high today of $23 ...

Shares of Hanover Insurance Rise Above P...

Shares of Hanover Insurance (NYSE:THG) traded at a new 52-week high today of $71.67. T ...

Recent 52-Week High Exceeded in Shares o...

Taubman Centers (NYSE:TCO) traded today at a new 52-week high of $79.47. So far today ...

Shares of Taser International Have Risen...

Taser International (NASDAQ:TASR) traded at a new 52-week high today of $22.35. Approx ...

Shares of Sunstone Hotel Investors Have ...

Sunstone Hotel Investors (NYSE:SHO) traded at a new 52-week high today of $15.93. This ...